Tracy Lieu to Cost-Benefit Analysis
This is a "connection" page, showing publications Tracy Lieu has written about Cost-Benefit Analysis.
Connection Strength
1.981
-
Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis. Lancet. 2007 Feb 03; 369(9559):389-96.
Score: 0.269
-
Cost-effectiveness of a routine varicella vaccination program for US children. JAMA. 1994 Feb 02; 271(5):375-81.
Score: 0.109
-
Clinical and cost-effectiveness of outpatient strategies for management of febrile infants. Pediatrics. 1992 Jun; 89(6 Pt 2):1135-44.
Score: 0.097
-
Effects of adverse events on the projected population benefits and cost-effectiveness of using live attenuated influenza vaccine in children aged 6 months to 4 years. Arch Pediatr Adolesc Med. 2011 Feb; 165(2):112-8.
Score: 0.087
-
Cost-effectiveness of rapid latex agglutination testing and throat culture for streptococcal pharyngitis. Pediatrics. 1990 Mar; 85(3):246-56.
Score: 0.083
-
New vaccines against otitis media: projected benefits and cost-effectiveness. Pediatrics. 2009 Jun; 123(6):1452-63.
Score: 0.079
-
Financial barriers to implementing combination vaccines: perspectives from pediatricians and policy makers. Clin Pediatr (Phila). 2009 Jun; 48(5):539-47.
Score: 0.078
-
Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster. Pharmacoeconomics. 2009; 27(12):1005-16.
Score: 0.077
-
Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness. Pharmacoeconomics. 2008; 26(2):163-78.
Score: 0.072
-
Community and patient values for preventing herpes zoster. Pharmacoeconomics. 2008; 26(3):235-49.
Score: 0.072
-
Cost effectiveness of pertussis vaccination in adults. Am J Prev Med. 2007 Mar; 32(3):186-193.
Score: 0.068
-
Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis. 2006 Oct; 12(10):1548-58.
Score: 0.066
-
Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites. Am J Prev Med. 2006 Jun; 30(6):498-506.
Score: 0.064
-
Pertussis in adolescents and adults: should we vaccinate? Pediatrics. 2005 Jun; 115(6):1675-84.
Score: 0.060
-
Values for preventing influenza-related morbidity and vaccine adverse events in children. Health Qual Life Outcomes. 2005 Mar 21; 3:18.
Score: 0.059
-
Emerging issues in vaccine economics: perspectives from the USA. Expert Rev Vaccines. 2002 Dec; 1(4):433-42.
Score: 0.050
-
Projected cost-effectiveness of statewide universal newborn hearing screening. Pediatrics. 2002 Nov; 110(5):855-64.
Score: 0.050
-
Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA. 2000 Mar 15; 283(11):1460-8.
Score: 0.042
-
Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants. Pediatrics. 1999 Sep; 104(3 Pt 1):419-27.
Score: 0.040
-
Issues in studying the effectiveness of health services for children. Health Serv Res. 1998 Oct; 33(4 Pt 2):1041-58.
Score: 0.038
-
Effectiveness and cost-effectiveness of letters, automated telephone messages, or both for underimmunized children in a health maintenance organization. Pediatrics. 1998 Apr; 101(4):E3.
Score: 0.036
-
Computer-based models to identify high-risk children with asthma. Am J Respir Crit Care Med. 1998 Apr; 157(4 Pt 1):1173-80.
Score: 0.036
-
Varicella serology among school age children with a negative or uncertain history of chickenpox. Pediatr Infect Dis J. 1998 Feb; 17(2):120-5.
Score: 0.036
-
Projected cost-effectiveness of primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 1997 Dec; 30(7):1741-50.
Score: 0.036
-
Evaluating Frameworks That Provide Value Measures for Health Care Interventions. Value Health. 2017 02; 20(2):185-192.
Score: 0.034
-
Computer-generated recall letters for underimmunized children: how cost-effective? Pediatr Infect Dis J. 1997 Jan; 16(1):28-33.
Score: 0.033
-
Cost-effectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescents. Pediatrics. 1995 May; 95(5):632-8.
Score: 0.030
-
Patients who self-monitor blood glucose and their unused testing results. Am J Manag Care. 2015 Feb 01; 21(2):e119-29.
Score: 0.029
-
The cost-effectiveness of prenatal carrier screening for cystic fibrosis. Obstet Gynecol. 1994 Dec; 84(6):903-12.
Score: 0.029
-
The cost of childhood chickenpox: parents' perspective. Pediatr Infect Dis J. 1994 Mar; 13(3):173-7.
Score: 0.027
-
Strategies for diagnosis and treatment of children at risk for occult bacteremia: clinical effectiveness and cost-effectiveness. J Pediatr. 1991 Jan; 118(1):21-9.
Score: 0.022
-
An economic analysis of the universal varicella vaccination program in the United States. J Infect Dis. 2008 Mar 01; 197 Suppl 2:S156-64.
Score: 0.018
-
Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia. Am J Gastroenterol. 2001 Feb; 96(2):338-47.
Score: 0.011
-
A comparison of health care experiences for medicaid and commercially enrolled children in a large, nonprofit health maintenance organization. Ambul Pediatr. 2001 Jan-Feb; 1(1):28-35.
Score: 0.011
-
Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente. Vaccine. 2000 Dec 08; 19 Suppl 1:S83-6.
Score: 0.011
-
The critical role of population-based epidemiology in cost-effectiveness research. Pediatrics. 2000 Apr; 105(4 Pt 1):862-3.
Score: 0.010
-
Preventing neonatal group B streptococcal disease: cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics. Pediatrics. 1999 Apr; 103(4 Pt 1):703-10.
Score: 0.010